The outlook of companies tied to Viagra's legacy presents a complex investment scenario . While the initial success generated substantial returns , generic competition have significantly eroded sales . Investing in connected pharmaceutical companies now requires a thorough assessment of proprietary safeguards, evolving healthcare trends , and the p